These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2187367)

  • 1. Occurrence, characteristics, and patterns of HIV-1 and HIV-2 western blot indeterminate sera in low risk populations in West Virginia and pre-AIDS Africa.
    Schindzielorz AH; Belshe RB; Mufson MA
    Am J Trop Med Hyg; 1990 May; 42(5):460-4. PubMed ID: 2187367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control study.
    Celum CL; Coombs RW; Jones M; Murphy V; Fisher L; Grant C; Corey L; Inui T; Wener MH; Holmes KK
    Arch Intern Med; 1994 May; 154(10):1129-37. PubMed ID: 7910452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of African sera stored for more than 17 years for HIV antibodies by site-directed serology.
    Chiodi F; Biberfeld G; Parks E; Norrby E; Mufson M
    Eur J Epidemiol; 1989 Mar; 5(1):42-6. PubMed ID: 2707394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter evaluation of a new recombinant enzyme immunoassay for the combined detection of antibody to HIV-1 and HIV-2.
    Ayres L; Avillez F; Garcia-Benito A; Deinhardt F; Gürtler L; Denis F; Léonard G; Ranger S; Grob P; Joller-Jemelka H
    AIDS; 1990 Feb; 4(2):131-8. PubMed ID: 2183814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of HIV-1 and HIV-2 indeterminate western blot patterns.
    Ayisi NK; Aidoo M
    West Afr J Med; 1994; 13(3):164-7. PubMed ID: 7841107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients.
    Cooper CJ; Metch B; Dragavon J; Coombs RW; Baden LR;
    JAMA; 2010 Jul; 304(3):275-83. PubMed ID: 20639561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying HIV-2-seropositive individuals by reevaluating HIV-1 indeterminate sera.
    Myers RA; Patel JD; Joseph JM
    J Acquir Immune Defic Syndr (1988); 1992; 5(4):417-23. PubMed ID: 1548577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of antibodies to human immunodeficiency virus 1 by a third-generation enzyme immunoassay. A comparative study with the results of second-generation immunoassays and western blot.
    Barbé F; Klein M; Badonnel Y
    Ann Biol Clin (Paris); 1994; 52(5):341-5. PubMed ID: 7856933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the Genie and western blot assays in confirmatory testing for HIV-1 antibody.
    Chan EL; Sidaway F; Horsman GB
    J Med Microbiol; 1996 Mar; 44(3):223-5. PubMed ID: 8636942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivity with SIVmac in east African HIV-1-positive sera: evidence against double infection with HIV-1 and a SIVmac/HIV-2-like virus.
    Blomberg J; Klasse PJ; Pehrson C
    Intervirology; 1990; 31(5):276-84. PubMed ID: 1703133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HIV indeterminate western blot in dialysis patients: a long-term follow-up.
    Vardinon N; Yust I; Katz O; Iaina A; Katzir Z; Modai D; Burke M
    Am J Kidney Dis; 1999 Jul; 34(1):146-9. PubMed ID: 10401029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Could saliva be used to detect HIV seroconversion?].
    Sangaré KA; Koffi AR; Coulibaly IM; Doulourou C
    Sante; 1997; 7(5):303-7. PubMed ID: 9480036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence of HIV 2 infection in Sicily.
    Russo Alesi D; Vitale F; Lupo G; La Licata R; Zambito F; Romano N
    Microbiologica; 1989 Jul; 12(3):195-201. PubMed ID: 2674633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Bio-Rad Geenius HIV-1/2 test as a confirmatory assay.
    Montesinos I; Eykmans J; Delforge ML
    J Clin Virol; 2014 Aug; 60(4):399-401. PubMed ID: 24932737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of evidence for HIV-2 infection among at-risk individuals in Brazil.
    Hendry RM; Parks DE; Mello DL; Quinnan GV; Castro BG
    J Acquir Immune Defic Syndr (1988); 1991; 4(6):623-7. PubMed ID: 2023103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiology of human immunodeficiency viruses in Africa.
    Fleming AF
    Biomed Pharmacother; 1988; 42(5):309-20. PubMed ID: 3191207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited evidence of human immunodeficiency virus type 2 (HIV-2) infection in sera from blood donors showing positive ELISA but negative or indeterminate western blot reactivity for HIV-1 infection.
    Chattopadhya D; Kumari S; Verghese T
    J Commun Dis; 1991 Sep; 23(3):206-7. PubMed ID: 1812169
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring blood donors for HIV-2 infection by testing anti-HIV-1 reactive sera.
    Busch MP; Petersen L; Schable C; Perkins H
    Transfusion; 1990 Feb; 30(2):184-7. PubMed ID: 1968296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of new peptide immunoassays versus other immunoassays and agglutination tests for detection of HIV antibody in African sera.
    Léonard G; Verdier M; Sangaré A; Rey JL; Denis F
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):636-40. PubMed ID: 1660808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of protection against HIV-1 infection among women with HIV-2 infection.
    Wiktor SZ; Nkengasong JN; Ekpini ER; Adjorlolo-Johnson GT; Ghys PD; Brattegaard K; Tossou O; Dondero TJ; De Cock KM; Greenberg AE
    AIDS; 1999 Apr; 13(6):695-9. PubMed ID: 10397564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.